Clinical Trial Update: TNF in Melanoma Patients Treated With Immunotherapy [NA]

View source ↗

Summary

A completed clinical trial sponsored by Institut Claudius Regaud studied tumor necrosis factor (TNF) in melanoma patients treated with immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Melanoma | NA | Status: COMPLETED